Vinay Prasad's acting replacement, remembering genomics pioneer J. Craig Venter, and more biotech news from The Readout ...

The FDA proposed excluding the active ingredients in popular obesity and diabetes drugs from a list of substances that can be ...

Most of the infant formula in the U.S. is safe, but experts and health officials say regulators can take steps to make the ...

Katherine Szarama, who joined the FDA last year to serve as Vinay Prasad’s deputy, will now fill his shoes at CBER.

J. Craig Venter, the scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized ...

At the hearing, the judge heard from mothers who lost sons to overdose, a teenager born into withdrawal, and people who spent ...

Efforts to make customized medicines at scale have hit commercial and regulatory roadblocks. Julia Vintarello is trying again ...

FDA review confirmed overall safety of 16 brands of baby formula. In a STAT Q&A, experts unpack what low-level PFAS findings ...

Psychedelics’ potential as a form of treatment is virtually unmatched. But their promise faces both scientific uncertainty ...

America is worried about fertility rates — again. Coverage of the country’s declining birth rate reflects widespread unease: ...

Examining the past statements and writings of Trump's third surgeon general nominee, Dr. Nicole Saphier, on vaccines, autism, ...

Why are investors excited about hair loss drugs? Will AI make clinical trials run more smoothly? And more in "The Readout ...